Developer docs
API playgroundTry for free, no card

Search company profiles

Ontada

Full company profile

uuid00074ps

Namestring
Ontada
Legal namestring
Ontada LLC
Websiteurl
ontada.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Ontada is an oncology-focused technology and real-world data company that operates as a wholly-owned subsidiary of McKesson Corporation, headquartered in Boston with operations in Atlanta. The company is built on the proprietary iKnowMed electronic health record system used by over 2,800 oncology providers across The US Oncology Network, which covers 35% of community oncologists and 600+ sites of care in 35 states. On top of iKnowMed, Ontada operates the ON.Genuity AI platform and a suite of data products including ON.Journey (longitudinal EHR + claims data), ON.Multiomics (clinico-molecular cohorts with Caris Life Sciences), Genospace (NGS-based precision medicine analytics), ON.Dispensing, ON.ClinicalDataView, ON.Insights, and Alerts, alongside the Ontada Learn provider education and engagement platform and dedicated real-world research services that have supported 450+ publications.

The underlying technology stack combines an oncology-specific EHR with AI and machine learning capabilities enhanced by a Microsoft Azure OpenAI collaboration that processes over 150 million unstructured oncology document components, multiomics data, claims data, and a certified API developer program. The company's commercial offering spans point-of-care decision support, biomarker and molecular profiling integration, near-real-time dispensing and treatment alerts, longitudinal outcomes data, and provider education channels reaching more than 13,000 physicians through partnerships such as OncoPrescribe.

Ontada generates revenue primarily through enterprise subscriptions and data licensing to pharmaceutical and biotech companies (its products are used by all top 15 global life sciences companies for oncology research, commercial strategy, and HEOR), EHR licensing and related modules to community oncology practices, professional services for real-world research from proposal to publication, and provider education and engagement services delivered to life sciences sponsors. Its operating geographies are limited to the United States, with no current international footprint disclosed, and its core customers are U.S. community oncology providers and global life sciences organizations.

Short descriptiontext

Ontada is an oncology technology and real-world data subsidiary of McKesson that provides the proprietary iKnowMed EHR, AI-powered RWD products, and provider education to community oncology providers and global life sciences companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology real-world data, oncology EHR software, community oncology insights, real-world evidence research, provider education oncology
Industry1 code
PRIMARYHLAKAFAB
Medical Oncology
NAICS code2 codes
  • Software Publishers513210
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Health Services8000
  • Services-Commercial Physical & Biological Research8731
Product category
Oncology Real-World Data and Insights
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Real-World Data Solutions for Life Sciences
TypeSubscription Recurring
Description

Ontada provides real-world oncology data solutions to pharmaceutical and life sciences companies for commercial strategy, HEOR, and research purposes. Revenue is generated through subscriptions to data products like ON.ClinicalDataView, ON.Insights, Alerts, and ON.Journey. These are typically multi-year contracts with pharmaceutical companies for access to clinical and biomarker data.

ontada.com
2EHR Technology Licensing
TypeSubscription Recurring
Description

iKnowMed EHR is provided to community oncology practices within The US Oncology Network. Revenue is derived from licensing the proprietary EHR system to oncology providers.

ontada.com
3Provider Education Services
TypeProfessional Services
Description

Ontada Learn provides digital education, practice-based education, meetings & events, and strategy services to life sciences companies seeking to engage oncology providers. This includes sponsorships, exhibits, and educational content delivery.

ontada.com
4Real-World Research Services
TypeProfessional Services
Description

Custom research engagements from proposal to publication, supporting 450+ real-world publications. Revenue generated through research service contracts with life sciences companies and healthcare organizations.

ontada.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 9 records shown
1Genospace
Description

Precision medicine platform leveraging next-generation sequencing patient data to generate market reports and precision insights for oncology research.

ontada.com
+8 more records
Core offering1 text field

Ontada sells a proprietary oncology EHR (iKnowMed) to community oncology providers and subscription-based real-world oncology data products (ON.Journey, ON.Multiomics, ON.ClinicalDataView, ON.Insights, Alerts, ON.Dispensing, Genospace) to pharmaceutical and biotech life sciences companies. It also delivers professional real-world research services spanning proposal to publication, and provider education and engagement programs through Ontada Learn for life sciences sponsors and oncology providers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Supported over 450+ real-world research publications
+4 more records
Product overview1 text field

Ontada is an oncology technology and insights business providing a platform of integrated products and services for real-world data, research, and provider education. The core platform combines proprietary EHR technology (iKnowMed) with real-world data products (ON.Journey, ON.Multiomics, Genospace, ON.ClinicalDataView, ON.Insights, Alerts, ON.Dispensing) and the AI-powered ON.Genuity platform. Provider engagement is delivered through Ontada Learn with sub-products including Digital Education, Meetings & Events, Practice-based Education, Strategy & Effectiveness, PeerTrax, and OncoPrescribe. Point-of-care capabilities include iKnowMed EHR, mobile app, patient portal, precision medicine module, practice analytics, and Clear Value Plus. Research services support the full lifecycle from proposal to publication across 450+ publications.

Product and service5 records
1iKnowMed
CategoryPoint-of-care EHR Software
Description

Proprietary web-based oncology EHR built by oncologists for oncologists, providing point-of-care treatment decision support, customizable features, mobile functionality, precision medicine module, and MIPS/OCM compliance for over 2,800 oncology providers in The US Oncology Network.

2ON.Journey
CategoryReal-World Data Subscription
Description

Longitudinal oncology real-world data product integrating iKnowMed EHR data with claims into a single standardized dataset covering 13 solid and hematologic tumor types and 150+ oncology-specific data elements for HEOR and research use.

3ON.Multiomics
CategoryReal-World Data Subscription
Description

Translational research data product combining molecular profiling from Caris Life Sciences (whole exome sequencing, whole transcriptome sequencing, IHC across 25+ biomarkers) with longitudinal clinical data from The US Oncology Network to deliver discovery-ready, biomarker-defined patient cohorts.

4ON.Genuity
CategoryData Platform
Description

AI-powered data platform combining Ontada's community oncology clinical dataset with advanced technology to generate robust, insight-rich real-world data at scale and speed.

5ON.ClinicalDataView
Scale indicator19 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Ontada collaborated with Datavant to enable faster access to market-leading oncology insights. Datavant Connect powered by AWS Clean Rooms provides privacy-preserving data collaboration without underlying data movement for clinical and commercial insights.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-10-17
Description

Ontada collaborated with Microsoft to utilize Azure AI, including Azure OpenAI Service, to process more than 150 million unstructured oncology document components. The collaboration enables delivery of quality unstructured data four times faster and provides life sciences clients more robust real-world data. Azure Batch API is leveraged for enhanced computing power and data processing at scale.

3U.S. Food and Drug Administration (FDA)
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2023-10-11
Description

Ontada was awarded a competitive FDA contract to investigate the natural history of rare cancers treated in the U.S. community oncology setting. Research aims to strengthen scientific understanding leveraging Ontada's community oncology footprint and unique RWD. Goal is to enhance understanding of how patients with rare cancers present and are treated.

ontada.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ON.Multiomics delivers discovery-ready, biomarker-defined patient cohorts linking comprehensive molecular profiling from Caris Life Sciences (Whole Exome Sequencing, Whole Transcriptome Sequencing, IHC across 25+ biomarkers) with longitudinal clinical data from The US Oncology Network for translational research analysis.

5The US Oncology Network
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Ontada's primary network partnership providing access to 35% of community oncologists across 600+ sites of care in 35 states. This partnership is foundational to Ontada's data, EHR, and provider education offerings. The US Oncology Network and McKesson Provider Solutions advance specialty care in communities where patients live.

ontada.com
6McKesson Precision Care Companion (PCC)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

McKesson launched Precision Care Companion consortium bringing together oncology practices, diagnostic labs, and biopharma partners to accelerate precision medicine adoption in community oncology settings. Deployed within The US Oncology Network spanning 12 practices, focusing on lung, colon, rectal, and prostate cancers.

mckesson.com
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Ontada contributed to the Enhancing Oncology Model (EOM) submission protocol for the White House Cancer Moonshot program, highlighting the company's role in combatting cancer and dedication to transforming cancer care.

Strategic tierCoreTypeTechnology or Integration
Description

Genospace, a precision medicine platform, united with Ontada to transform cancer care through biomarker-driven therapies. Genospace uses patient data from next-generation sequencing to create market reports and leverages real-world evidence for genomics in cancer progression.

9Sarah Cannon Research Institute
Strategic tierCoreTypeStrategic or Co-development Partner
Description

McKesson joint venture with Sarah Cannon Research Institute helping patients participate in cutting-edge clinical trials closer to home. Part of the broader oncology ecosystem supporting community-based oncology.

ontada.com
10OncoPrescribe
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive partnership with OncoPrescribe makes it easier for oncologists to stay educated on changing information like biomarkers, treatment options, and disease management. Through OncoPrescribe website and weekly newsletter, reach more than 13,000 subscribers including 10,000+ physicians.

ontada.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

BeiGene announced strategic alliance with Ontada in 2022 to improve U.S. community oncology care.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Ontada signed strategic agreement with Merck in 2021 to facilitate the development of data-driven insights to impact quality of cancer care.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Amgen and McKesson launched strategic agreement in 2020 to advance cancer innovation in communities.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Tempus
TypeDirect peer
Description

AI-enabled precision medicine company combining multiomics (DNA/RNA sequencing) with clinical and molecular data to serve oncologists, pharma, and researchers; directly comparable as an oncology data, sequencing, and insights platform.

TypeDirect peer
Description

Oncology real-world evidence company that curates clinical data from EHRs for life sciences research and value-based care; directly comparable as an oncology-specific RWD/RWE vendor serving pharma and providers.

TypeDirect peer
Description

Oncology-focused real-world data and AI SaaS company serving life sciences with synthetic control arms, clinical trial design, and HEOR research; competes for the same pharma RWE engagements as ON.Journey and ON.ClinicalDataView.

TypeDirect peer
Description

Direct peer offering oncology-specific EHR (OncoEMR) and real-world evidence to community oncology practices and life sciences; the most analogous scaled competitor to Ontada, now part of Roche, and competes head-to-head for pharma RWD budgets.

TypeBroad incumbent
Description

Global CRO and real-world data giant with oncology-specific linked data assets and EDC/CTMS offerings; overlaps with Ontada's life sciences RWE/research services as a broad incumbent rather than a niche specialist.

TypeEmerging player
Description

Liquid biopsy and precision oncology company with growing real-world clinico-genomic data products for pharma and providers; overlaps with ON.Multiomics on biomarker and molecular evidence use cases for oncology drug development.

TypeDirect peer
Description

Real-world evidence platform focused on oncology precision medicine, integrating molecular and clinical data to support pharma decisions; competes for biomarker-defined cohort and translational RWE use cases overlapping ON.Multiomics.

TypeEmerging player
Description

Roche-owned molecular profiling and genomic data company whose FoundationCore clinico-genomic database overlaps with ON.Multiomics; comparable as a clinico-molecular data partner for pharma R&D.

9McKesson Corporation
TypeBroad incumbent
Description

Ontada's parent company, a diversified healthcare distributor owning US Oncology Network, Sarah Cannon Research Institute, and drug distribution; comparable as the broader oncology services ecosystem within which Ontada operates and competes for adjacent spend.

10Palanigo / STRATA Health Sciences
TypeEmerging player
Description

Real-world data analytics platform used by pharma and payers for treatment pattern insights; comparable as an emerging RWD analytics vendor competing for life sciences commercial and HEOR budgets adjacent to ON.Insights.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ontada

Oncology Real-World Data and Insightsontada.com

Ontada is an oncology technology and real-world data subsidiary of McKesson that provides the proprietary iKnowMed EHR, AI-powered RWD products, and provider education to community oncology providers and global life sciences companies.

What Ontada does

Ontada is an oncology-focused technology and real-world data company that operates as a wholly-owned subsidiary of McKesson Corporation, headquartered in Boston with operations in Atlanta. The company is built on the proprietary iKnowMed electronic health record system used by over 2,800 oncology providers across The US Oncology Network, which covers 35% of community oncologists and 600+ sites of care in 35 states. On top of iKnowMed, Ontada operates the ON.Genuity AI platform and a suite of data products including ON.Journey (longitudinal EHR + claims data), ON.Multiomics (clinico-molecular cohorts with Caris Life Sciences), Genospace (NGS-based precision medicine analytics), ON.Dispensing, ON.ClinicalDataView, ON.Insights, and Alerts, alongside the Ontada Learn provider education and engagement platform and dedicated real-world research services that have supported 450+ publications.

The underlying technology stack combines an oncology-specific EHR with AI and machine learning capabilities enhanced by a Microsoft Azure OpenAI collaboration that processes over 150 million unstructured oncology document components, multiomics data, claims data, and a certified API developer program. The company's commercial offering spans point-of-care decision support, biomarker and molecular profiling integration, near-real-time dispensing and treatment alerts, longitudinal outcomes data, and provider education channels reaching more than 13,000 physicians through partnerships such as OncoPrescribe.

Ontada generates revenue primarily through enterprise subscriptions and data licensing to pharmaceutical and biotech companies (its products are used by all top 15 global life sciences companies for oncology research, commercial strategy, and HEOR), EHR licensing and related modules to community oncology practices, professional services for real-world research from proposal to publication, and provider education and engagement services delivered to life sciences sponsors. Its operating geographies are limited to the United States, with no current international footprint disclosed, and its core customers are U.S. community oncology providers and global life sciences organizations.

Ontada firmographics

Firmographics
Name
Ontada
Legal name
Ontada LLC
Website
https://ontada.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
101–250 employees
Short description
Ontada is an oncology technology and real-world data subsidiary of McKesson that provides the proprietary iKnowMed EHR, AI-powered RWD products, and provider education to community oncology providers and global life sciences companies.
Ownership category
akta.pro rank

Ontada industry classification

Industry
Product category
Oncology Real-World Data and Insights
NAICS
Software Publishers (513210), Scientific Research and Development Services (5417)
SIC
Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAKAFAB
Medical Oncology

Keywords

  • Oncology real-world data
  • Oncology EHR software
  • Community oncology insights
  • Real-world evidence research
  • Provider education oncology

Where Ontada is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Ontada business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Real-World Data Solutions for Life Sciences: Ontada provides real-world oncology data solutions to pharmaceutical and life sciences companies for commercial strategy, HEOR, and research purposes. Revenue is generated through subscriptions to data products like ON.ClinicalDataView, ON.Insights, Alerts, and ON.Journey. These are typically multi-year contracts with pharmaceutical companies for access to clinical and biomarker data.
  2. EHR Technology Licensing: iKnowMed EHR is provided to community oncology practices within The US Oncology Network. Revenue is derived from licensing the proprietary EHR system to oncology providers.
  3. Provider Education Services: Ontada Learn provides digital education, practice-based education, meetings & events, and strategy services to life sciences companies seeking to engage oncology providers. This includes sponsorships, exhibits, and educational content delivery.
  4. Real-World Research Services: Custom research engagements from proposal to publication, supporting 450+ real-world publications. Revenue generated through research service contracts with life sciences companies and healthcare organizations.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Ontada product offering

Product offering

Core offering

Ontada sells a proprietary oncology EHR (iKnowMed) to community oncology providers and subscription-based real-world oncology data products (ON.Journey, ON.Multiomics, ON.ClinicalDataView, ON.Insights, Alerts, ON.Dispensing, Genospace) to pharmaceutical and biotech life sciences companies. It also delivers professional real-world research services spanning proposal to publication, and provider education and engagement programs through Ontada Learn for life sciences sponsors and oncology providers.

Product overview

Ontada is an oncology technology and insights business providing a platform of integrated products and services for real-world data, research, and provider education. The core platform combines proprietary EHR technology (iKnowMed) with real-world data products (ON.Journey, ON.Multiomics, Genospace, ON.ClinicalDataView, ON.Insights, Alerts, ON.Dispensing) and the AI-powered ON.Genuity platform. Provider engagement is delivered through Ontada Learn with sub-products including Digital Education, Meetings & Events, Practice-based Education, Strategy & Effectiveness, PeerTrax, and OncoPrescribe. Point-of-care capabilities include iKnowMed EHR, mobile app, patient portal, precision medicine module, practice analytics, and Clear Value Plus. Research services support the full lifecycle from proposal to publication across 450+ publications.

Differentiator

Problem solved

Functional benefit

Brands

  • Genospace: Precision medicine platform leveraging next-generation sequencing patient data to generate market reports and precision insights for oncology research.
  • iKnowMed
  • ON.Dispensing
  • ON.Journey
  • ON.Insights
  • ON.ClinicalDataView
  • Alerts
  • ON.Multiomics
  • Ontada Learn

Products and services

  • iKnowMed Proprietary web-based oncology EHR built by oncologists for oncologists, providing point-of-care treatment decision support, customizable features, mobile functionality, precision medicine module, and MIPS/OCM compliance for over 2,800 oncology providers in The US Oncology Network.
  • ON.Journey Longitudinal oncology real-world data product integrating iKnowMed EHR data with claims into a single standardized dataset covering 13 solid and hematologic tumor types and 150+ oncology-specific data elements for HEOR and research use.
  • ON.Multiomics Translational research data product combining molecular profiling from Caris Life Sciences (whole exome sequencing, whole transcriptome sequencing, IHC across 25+ biomarkers) with longitudinal clinical data from The US Oncology Network to deliver discovery-ready, biomarker-defined patient cohorts.
  • ON.Genuity AI-powered data platform combining Ontada's community oncology clinical dataset with advanced technology to generate robust, insight-rich real-world data at scale and speed.
  • ON.ClinicalDataView

Quantifiable outcome

  • Supported over 450+ real-world research publications
  • +4 more outcomes

Companies that use Ontada

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Ontada technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability9 records

Feature8 records

Ontada partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core, flagship and minor.

  • DatavantcoreStrategic or Co-development Partner · 1 January 2025Ontada collaborated with Datavant to enable faster access to market-leading oncology insights. Datavant Connect powered by AWS Clean Rooms provides privacy-preserving data collaboration without underlying data movement for clinical and commercial insights.
  • MicrosoftcoreTechnology or Integration · 17 October 2024Ontada collaborated with Microsoft to utilize Azure AI, including Azure OpenAI Service, to process more than 150 million unstructured oncology document components. The collaboration enables delivery of quality unstructured data four times faster and provides life sciences clients more robust real-world data. Azure Batch API is leveraged for enhanced computing power and data processing at scale.
  • U.S. Food and Drug Administration (FDA)flagshipStrategic or Co-development Partner · 11 October 2023Ontada was awarded a competitive FDA contract to investigate the natural history of rare cancers treated in the U.S. community oncology setting. Research aims to strengthen scientific understanding leveraging Ontada's community oncology footprint and unique RWD. Goal is to enhance understanding of how patients with rare cancers present and are treated.
  • Caris Life SciencescoreStrategic or Co-development PartnerON.Multiomics delivers discovery-ready, biomarker-defined patient cohorts linking comprehensive molecular profiling from Caris Life Sciences (Whole Exome Sequencing, Whole Transcriptome Sequencing, IHC across 25+ biomarkers) with longitudinal clinical data from The US Oncology Network for translational research analysis.
  • The US Oncology NetworkflagshipStrategic or Co-development PartnerOntada's primary network partnership providing access to 35% of community oncologists across 600+ sites of care in 35 states. This partnership is foundational to Ontada's data, EHR, and provider education offerings. The US Oncology Network and McKesson Provider Solutions advance specialty care in communities where patients live.
  • McKesson Precision Care Companion (PCC)coreStrategic or Co-development PartnerMcKesson launched Precision Care Companion consortium bringing together oncology practices, diagnostic labs, and biopharma partners to accelerate precision medicine adoption in community oncology settings. Deployed within The US Oncology Network spanning 12 practices, focusing on lung, colon, rectal, and prostate cancers.
  • White House Cancer MoonshotflagshipStrategic or Co-development PartnerOntada contributed to the Enhancing Oncology Model (EOM) submission protocol for the White House Cancer Moonshot program, highlighting the company's role in combatting cancer and dedication to transforming cancer care.
  • GenospacecoreTechnology or IntegrationGenospace, a precision medicine platform, united with Ontada to transform cancer care through biomarker-driven therapies. Genospace uses patient data from next-generation sequencing to create market reports and leverages real-world evidence for genomics in cancer progression.
  • Sarah Cannon Research InstitutecoreStrategic or Co-development PartnerMcKesson joint venture with Sarah Cannon Research Institute helping patients participate in cutting-edge clinical trials closer to home. Part of the broader oncology ecosystem supporting community-based oncology.
  • OncoPrescribecoreChannel Partner/ Reseller/ DistributorExclusive partnership with OncoPrescribe makes it easier for oncologists to stay educated on changing information like biomarkers, treatment options, and disease management. Through OncoPrescribe website and weekly newsletter, reach more than 13,000 subscribers including 10,000+ physicians.
  • BeiGeneminorStrategic or Co-development PartnerBeiGene announced strategic alliance with Ontada in 2022 to improve U.S. community oncology care.
  • MerckminorStrategic or Co-development PartnerOntada signed strategic agreement with Merck in 2021 to facilitate the development of data-driven insights to impact quality of cancer care.
  • AmgenminorStrategic or Co-development PartnerAmgen and McKesson launched strategic agreement in 2020 to advance cancer innovation in communities.

Scale indicators19 records

Recent moves7 records

Expansion highlights6 records

Ontada competitors and assessment

Company assessment

Direct peers

  • Tempus: AI-enabled precision medicine company combining multiomics (DNA/RNA sequencing) with clinical and molecular data to serve oncologists, pharma, and researchers; directly comparable as an oncology data, sequencing, and insights platform.
  • COTA Healthcare: Oncology real-world evidence company that curates clinical data from EHRs for life sciences research and value-based care; directly comparable as an oncology-specific RWD/RWE vendor serving pharma and providers.
  • ConcertAI: Oncology-focused real-world data and AI SaaS company serving life sciences with synthetic control arms, clinical trial design, and HEOR research; competes for the same pharma RWE engagements as ON.Journey and ON.ClinicalDataView.
  • Flatiron Health: Direct peer offering oncology-specific EHR (OncoEMR) and real-world evidence to community oncology practices and life sciences; the most analogous scaled competitor to Ontada, now part of Roche, and competes head-to-head for pharma RWD budgets.
  • Syapse: Real-world evidence platform focused on oncology precision medicine, integrating molecular and clinical data to support pharma decisions; competes for biomarker-defined cohort and translational RWE use cases overlapping ON.Multiomics.

Broad incumbents

  • IQVIA (Oncology RWD): Global CRO and real-world data giant with oncology-specific linked data assets and EDC/CTMS offerings; overlaps with Ontada's life sciences RWE/research services as a broad incumbent rather than a niche specialist.
  • McKesson Corporation: Ontada's parent company, a diversified healthcare distributor owning US Oncology Network, Sarah Cannon Research Institute, and drug distribution; comparable as the broader oncology services ecosystem within which Ontada operates and competes for adjacent spend.

Emerging players

  • Guardant Health: Liquid biopsy and precision oncology company with growing real-world clinico-genomic data products for pharma and providers; overlaps with ON.Multiomics on biomarker and molecular evidence use cases for oncology drug development.
  • Foundation Medicine: Roche-owned molecular profiling and genomic data company whose FoundationCore clinico-genomic database overlaps with ON.Multiomics; comparable as a clinico-molecular data partner for pharma R&D.
  • Palanigo / STRATA Health Sciences: Real-world data analytics platform used by pharma and payers for treatment pattern insights; comparable as an emerging RWD analytics vendor competing for life sciences commercial and HEOR budgets adjacent to ON.Insights.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Ontada social profiles

Digital presence

Ontada compliance and trust

Trust signal

Compliance3 records

Ontada financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ontada leadership team

Management profile

Number of profiles

Profiles12 records

Ontada subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Ontada funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ontada M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ontada

What does Ontada do?

Ontada sells a proprietary oncology EHR (iKnowMed) to community oncology providers and subscription-based real-world oncology data products (ON.Journey, ON.Multiomics, ON.ClinicalDataView, ON.Insights, Alerts, ON.Dispensing, Genospace) to pharmaceutical and biotech life sciences companies. It also delivers professional real-world research services spanning proposal to publication, and provider education and engagement programs through Ontada Learn for life sciences sponsors and oncology providers.

Is Ontada a public or private company?

Ontada is a private company. It is classified as corporate owned and is currently operating.

When was Ontada founded?

Ontada was founded in 2020. It employs 101 to 250 people.

Where is Ontada based?

Ontada is headquartered in Boston, United States, in the North America region.

How does Ontada make money?

Four revenue lines are on record. Real-World Data Solutions for Life Sciences are the primary driver. The others are EHR Technology Licensing, provider Education Services and real-World Research Services.

Who are Ontada's main competitors?

Direct peers on record are Tempus, COTA Healthcare, ConcertAI, Flatiron Health and Syapse. Broad incumbents are IQVIA (Oncology RWD) and McKesson Corporation. Emerging players are Guardant Health, Foundation Medicine and Palanigo / STRATA Health Sciences.

Does Ontada have an API?

Yes. Ontada offers a Certified API Developer Program with self-service certification. Developers can access APIs through the API Portal to build integrations with iKnowMed. The Value Add Developer Program (by invitation) provides access to additional APIs beyond certified APIs, sandboxes, richer test data sets, and tools for workflow integration. Developers can also publish products in the Ontada Marketplace. FHIR standards are referenced for interoperability. Developer documentation is at apiaccess.mckesson.com/apiportal-service/#/login.

What industry is Ontada in?

Ontada's product category is Oncology Real-World Data and Insights. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology. Its NAICS code is 513210 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageOntada Advances the Intelligent Medical Record with Integrated AI Capabilities for iKnowMedOntada announced new AI capabilities for its iKnowMed platform, including ambient documentation, summarization, smart coding, practice assistance, and dictation. The features are available to all iKnowMed customers, developed with Commure, and aim to reduce administrative burden for oncology practices.Clinical Trials ArenaASCO26: GLP-1RAs linked with mortality reduction in patients with solid tumoursAt ASCO 2026, real-world data studies linked GLP-1 receptor agonists to reduced mortality in solid tumour patients. One study found nearly a 35% reduction in death rates among users, while another reported a 34% reduction. Researchers noted the need to identify which patients would most benefit.Pharmacy TimesReal-World Use of Talazoparib Plus Enzalutamide and HR Testing Trends in Prostate CancerA real-world analysis conducted by Ontada evaluated the use of talazoparib (Talzenna) plus enzalutamide (Xtandi) in patients with metastatic castration-resistant prostate cancer treated in community oncology settings. The findings show the drug combination is largely being used in alignment with its FDA-approved indication for HR-mutated mCRPC, though treatment sequencing and prior androgen receptor pathway inhibitor exposure varied across patients. The research also highlights the growing importance of earlier HR biomarker testing in prostate cancer management as NCCN guidelines increasingly support broader testing to guide targeted therapy decisions.Business Wire BlogOntada Presents 12 Real-World Research Studies at ISPOR 2026Ontada will present 12 real-world research posters and introduce ON.Journey, a new oncology data solution, at ISPOR 2026. The posters cover treatment adoption, outcomes, and patterns of care in community oncology, with ON.Journey built using AI and natural language processing on proprietary electronic medical records.PR NewswireDeepScribe Introduces SmartPrep, Comprehensive Pre-Visit Intelligence for OncologyDeepScribe, the ambient AI leader for oncology, announced SmartPrep, a pre-visit clinical intelligence product that automatically gathers and organizes relevant clinical information for oncologists before patient encounters. The product, currently available on Ontada's IKnowMed EHR and Flatiron Health's OncoEMR platforms, is designed for both initial consults and follow-up visits, synthesizing patient history, imaging results, and pathology findings. Clinicians using SmartPrep report spending about one-third as much time preparing for each oncology patient as they had previously.OncoDailyZhaohui Su: Target Trial Emulation and High-Quality RWD for Regulatory-Grade EvidenceZhaohui Su, VP of Biostatistics at Ontada, and Massoud Toussi discussed the application of Target Trial Emulation (TTE) to real-world data for generating regulatory-grade evidence. The dialogue highlights how TTE aligns observational studies with randomized trial principles to reduce bias, addressing longstanding concerns about RWE reliability. This approach is positioned as critical for meeting new 2025 TARGET guidelines and FDA submission standards.OncoDailyZhaohui Su: Strengthening Real-World Evidence with Quantitative Bias AnalysisZhaohui Su, Vice President of Biostatistics at Ontada, discusses the introduction of Quantitative Bias Analysis (QBA) as a methodology for enhancing the reliability of external control arms derived from real-world data in clinical trials, particularly for rare cancers. The article presents QBA's application in evaluating trial data against real-world outcomes for RET fusion-positive advanced non-small cell lung cancer, highlighting its importance in addressing systematic errors that conventional statistical methods cannot. This methodology aims to improve the credibility of efficacy estimates, supporting researchers and decision-makers in regulatory interpretations.TrinitylifesciencesTrinity Expands Data Partnership for Oncology InsightsTrinity Life Sciences announced a strategic collaboration with Ontada, a business of McKesson, to leverage advanced analytics and community oncology insights. The partnership combines Trinity's commercial analytics expertise with Ontada's proprietary iKnowMed® electronic health record data to provide real-time intelligence for life sciences companies. This alliance aims to improve provider outreach, patient care, and strategic decision-making in the oncology sector.openPR.comPrecision Medicine Market Boosted by AI Integration and Personalized Treatment Demand | Thermo Fisher Scientific Inc., AstraZeneca, Pfizer Inc., GSK plc, BiogenThe precision medicine market reached US$98.87 billion in 2024 and is projected to reach US$329.73 billion by 2033, a CAGR of 14.8%. Growth is driven by AI integration and personalized treatment demand, with recent partnerships including McKesson's Precision Care Companion and Caris Life Sciences' collaboration with Ontada.CarislifesciencesCaris Life Sciences Announces a Strategic Collaboration with OntadaCaris Life Sciences and Ontada announced a strategic collaboration to combine Caris's genomic data with Ontada's clinical real-world evidence for oncology research. This partnership aims to accelerate the development of next-generation precision medicine therapies by leveraging over 6.5 million tests and 2.4 million patient records.